| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1033615667 |
| P356 | DOI | 10.1038/SJ.ONC.1204067 |
| P698 | PubMed publication ID | 11313951 |
| P5875 | ResearchGate publication ID | 12020764 |
| P2093 | author name string | Boxer LM | |
| Heckman CA | |||
| Arcinas M | |||
| Mehew JW | |||
| Wu Y | |||
| P2860 | cites work | Wild-type p53 binds to the TATA-binding protein and represses transcription | Q24300991 |
| Identification of a novel p53 functional domain that is necessary for efficient growth suppression | Q24311276 | ||
| CREB proteins function as positive regulators of the translocated bcl-2 allele in t(14;18) lymphomas | Q24321494 | ||
| Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression | Q24336035 | ||
| The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression | Q24533291 | ||
| Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3 | Q24648290 | ||
| p53, the cellular gatekeeper for growth and division | Q27860990 | ||
| Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis | Q28144256 | ||
| Histone deacetylase activity is required for full transcriptional repression by mSin3A | Q28238079 | ||
| Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression | Q28238089 | ||
| p21 is a universal inhibitor of cyclin kinases | Q28257305 | ||
| Rb interacts with histone deacetylase to repress transcription | Q28263985 | ||
| Tumor suppressor p53 is a direct transcriptional activator of the human bax gene | Q28306186 | ||
| p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor | Q28609751 | ||
| p53: puzzle and paradigm | Q29618407 | ||
| Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest | Q33774492 | ||
| Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. | Q33775085 | ||
| Transcriptional repression by the SMRT-mSin3 corepressor: multiple interactions, multiple mechanisms, and a potential role for TFIIB. | Q33779119 | ||
| Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein | Q34343950 | ||
| The p53 proto-oncogene can act as a suppressor of transformation | Q34440370 | ||
| Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation | Q34559025 | ||
| Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. | Q35207550 | ||
| Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma | Q35617276 | ||
| Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein | Q35755347 | ||
| Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis | Q36562739 | ||
| A negative regulatory element in the bcl-2 5'-untranslated region inhibits expression from an upstream promoter | Q36686916 | ||
| Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding | Q36706865 | ||
| Negative regulation of Rb expression by the p53 gene product | Q37049477 | ||
| Overlap of the p53-responsive element and cAMP-responsive element in the enhancer of human T-cell leukemia virus type I | Q37058260 | ||
| Wild-type p53 can down-modulate the activity of various promoters | Q37617210 | ||
| Bcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn-3a POU family transcription factor | Q38336118 | ||
| p53 expression in lymphatic malignancies | Q39398079 | ||
| Pi 1 binding sites are negative regulators of bcl-2 expression in pre-B cells | Q40016702 | ||
| A-Myb up-regulates Bcl-2 through a Cdx binding site in t(14;18) lymphoma cells. | Q40897795 | ||
| p53 in growth control and neoplasia | Q41009705 | ||
| The polyproline region of p53 is required to activate apoptosis but not growth arrest. | Q41093439 | ||
| Overexpression of the MDM2 oncogene in leukemia and lymphoma | Q41489317 | ||
| Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. | Q41553241 | ||
| Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. | Q41643433 | ||
| Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study. | Q44427938 | ||
| A novel form of Epstein-Barr virus latency in normal B cells in vivo | Q45789413 | ||
| The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining | Q48375088 | ||
| P53 protein expression in lymphomas and reactive lymphoid tissue | Q67542214 | ||
| Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer | Q68918964 | ||
| Immunohistochemical detection of p53, bcl-2, and retinoblastoma proteins in follicular lymphoma | Q71064050 | ||
| Changes in Bcl-2 and p53 expression in recurrent B-cell lymphomas | Q71870877 | ||
| Heterogeneity in cell proliferation and expression of p53 and bcl-2 during the indolent phase of germinal centre cell lymphoma: an explanation for clinical variability | Q72046338 | ||
| Apoptosis and proliferative activity of non-Hodgkin's lymphomas: comparison with expression of bcl-2, p53 and c-myc proteins | Q73192364 | ||
| Effects of dehydroepiandrosterone and calorie restriction on the Bcl-2/Bax-mediated apoptotic pathway in p53-deficient mice | Q73401624 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 240-251 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Negative regulation of bcl-2 expression by p53 in hematopoietic cells | |
| P478 | volume | 20 |
| Q41908813 | A DR4:tBID axis drives the p53 apoptotic response by promoting oligomerization of poised BAX. |
| Q34584528 | A genetic variant of p53 restricts the mucous secretory phenotype by regulating SPDEF and Bcl-2 expression. |
| Q36681959 | A novel SATB1 binding site in the BCL2 promoter region possesses transcriptional regulatory function |
| Q42059305 | A p38MAPK-p53 cascade regulates mesodermal differentiation and neurogenesis of embryonic stem cells |
| Q36016499 | A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansion |
| Q34572898 | A role for p53 in the frequency and mechanism of mutation |
| Q38332936 | A transcriptional regulatory element in the coding sequence of the human Bcl-2 gene. |
| Q36210284 | AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin |
| Q40628992 | Adenovirus 2 E1B-55K protein relieves p53-mediated transcriptional repression of the survivin and MAP4 promoters |
| Q92891569 | Alantolactone suppresses human osteosarcoma through the PI3K/AKT signaling pathway |
| Q51511748 | Apoptosis and expression of the Bcl-2 family of proteins and P53 in human pancreatic ductal adenocarcinoma. |
| Q34520432 | Apoptosis: a link between cancer genetics and chemotherapy |
| Q35595410 | Apoptotic pathways activated by histone deacetylase inhibitors: implications for the drug-resistant phenotype |
| Q37522376 | BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53. |
| Q45050515 | Bi-directional regulation between tyrosine kinase Etk/BMX and tumor suppressor p53 in response to DNA damage |
| Q40592113 | CMV promoter is repressed by p53 and activated by JNK pathway |
| Q37790163 | Candidate genes and potential targets for therapeutics in Wilms’ tumour |
| Q38911126 | Census and evaluation of p53 target genes. |
| Q33767881 | Combination of 9-aminoacridine with Campath-1H provides effective therapy for a murine model of adult T-cell leukemia |
| Q36642752 | Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells |
| Q34455157 | Conditional gene targeting for cancer gene therapy |
| Q37381120 | Cyclin-dependent kinase 1 inhibitor RO-3306 enhances p53-mediated Bax activation and mitochondrial apoptosis in AML |
| Q35752372 | Cyclooxygenase-2 induction by arsenite through the IKKbeta/NFkappaB pathway exerts an antiapoptotic effect in mouse epidermal Cl41 cells |
| Q43140225 | Cytoplasmic sequestration of p53 promotes survival in leukocytes transformed by Theileria |
| Q37656349 | DNA damage-binding complex recruits HDAC1 to repress Bcl-2 transcription in human ovarian cancer cells |
| Q49374158 | DZNep represses Bcl-2 expression and modulates apoptosis sensitivity in response to Nutlin-3a |
| Q33761586 | Dependence of p53-deficient cells on the DHX9 DExH-box helicase |
| Q39030857 | Dicoumarol sensitizes renal cell carcinoma Caki cells to TRAIL-induced apoptosis through down-regulation of Bcl-2, Mcl-1 and c-FLIP in a NQO1-independent manner |
| Q53703877 | Differential mRNA expression of the main apoptotic proteins in normal and malignant cells and its relation to in vitro resistance. |
| Q43847020 | Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism. |
| Q40612658 | Effect of haemopoietic growth factors on cancer cell lines and their role in chemosensitivity |
| Q61447347 | Ell3 functions as a critical decision maker at the crossroad between stem cell senescence and apoptosis |
| Q37383705 | Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells |
| Q42138210 | Expression of LGI1 Impairs Proliferation and Survival of HeLa Cells |
| Q40034771 | Expression of androgen receptor is negatively regulated by p53. |
| Q33291582 | Expression of hereditary hemochromatosis C282Y HFE protein in HEK293 cells activates specific endoplasmic reticulum stress responses |
| Q28584218 | FGF1 inhibits p53-dependent apoptosis and cell cycle arrest via an intracrine pathway |
| Q79751169 | Failure of stress-induced downregulation of Bcl-2 contributes to apoptosis resistance in senescent human diploid fibroblasts |
| Q37761970 | Focal adhesion kinase and p53 signal transduction pathways in cancer |
| Q36921742 | Focal adhesion kinase and p53 signaling in cancer cells |
| Q40601158 | Guanine nucleotide depletion triggers cell cycle arrest and apoptosis in human neuroblastoma cell lines |
| Q33860585 | Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas |
| Q36346936 | IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity. |
| Q36529009 | Identification of a novel Bcl-2 promoter region that counteracts in a p53-dependent manner the inhibitory P2 region. |
| Q43084011 | In vitro anticancer effect of venom from Cuban scorpion Rhopalurus junceus against a panel of human cancer cell lines |
| Q35131580 | Insights into the mitochondrial signaling pathway: what lessons for chemotherapy? |
| Q36249132 | Interferon regulatory factor 4 binding protein is a novel p53 target gene and suppresses cisplatin-induced apoptosis of breast cancer cells |
| Q58695202 | Knockdown of BCL6 Inhibited Malignant Phenotype and Enhanced Sensitivity of Glioblastoma Cells to TMZ through AKT Pathway |
| Q55669681 | Luteoloside Inhibits Proliferation and Promotes Intrinsic and Extrinsic Pathway-Mediated Apoptosis Involving MAPK and mTOR Signaling Pathways in Human Cervical Cancer Cells. |
| Q37710558 | Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance |
| Q36218273 | Mdm2 overexpression and p73 loss exacerbate genomic instability and dampen apoptosis, resulting in B-cell lymphoma |
| Q36687760 | Mechanisms of doxorubicin resistance in hepatocellular carcinoma |
| Q40481710 | Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/ 5-fluorocytosine suicide gene therapy-induced cell death in glioma cells. |
| Q47416965 | Mechanisms of transcriptional regulation by p53. |
| Q40399548 | Mitochondrial localization of p53 during adenovirus infection and regulation of its activity by E1B-19K. |
| Q33852777 | Modulation of cellular signaling pathways in P23H rhodopsin photoreceptors |
| Q40729431 | NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells |
| Q37981834 | New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy |
| Q28080158 | Non-Canonical Cell Death Induced by p53 |
| Q39202885 | Notch activation inhibits AML growth and survival: a potential therapeutic approach |
| Q81267242 | Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression |
| Q34132206 | Oestrogen prevents cardiomyocyte apoptosis by suppressing p38α-mediated activation of p53 and by down-regulating p53 inhibition on p38β |
| Q37857673 | One function--multiple mechanisms: the manifold activities of p53 as a transcriptional repressor |
| Q50093685 | Orai3 calcium channel and resistance to chemotherapy in breast cancer cells: the p53 connection. |
| Q47368506 | PLK4: a link between centriole biogenesis and cancer |
| Q36961965 | Pathophysiological Significance of Hepatic Apoptosis |
| Q24310675 | Phosphorylation of Pirh2 by calmodulin-dependent kinase II impairs its ability to ubiquitinate p53 |
| Q34372160 | Plumbagin reduces human colon cancer cell survival by inducing cell cycle arrest and mitochondria-mediated apoptosis |
| Q87374333 | Positive immunohistochemical expression of bcl-2 in hormone-independent breast carcinomas is associated with a greater lymph node involvement and poor outcome |
| Q39188578 | Pramanicin analog induces apoptosis in human colon cancer cells: critical roles for Bcl-2, Bim, and p38 MAPK signaling. |
| Q36310873 | Regulation of anti-apoptotic Bcl-2 family protein Mcl-1 by S6 kinase 2 |
| Q43819783 | Regulation of the cellular prion protein gene expression depends on chromatin conformation |
| Q45000475 | Repression of hsp90beta gene by p53 in UV irradiation-induced apoptosis of Jurkat cells |
| Q34390964 | Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy. |
| Q24550864 | SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing |
| Q92890209 | Shikonin potentiates paclitaxel antitumor efficacy in esophageal cancer cells via the apoptotic pathway |
| Q42454028 | Simultaneous exposure to dietary acrylamide and corn oil developed carcinogenesis through cell proliferation and inhibition of apoptosis by regulating p53-mediated mitochondria-dependent signaling pathway |
| Q67994576 | Structured Reviews for Data and Knowledge Driven Research |
| Q91866899 | Structured reviews for data and knowledge-driven research |
| Q37339461 | Suppression of MicroRNA 200 Family Expression by Oncogenic KRAS Activation Promotes Cell Survival and Epithelial-Mesenchymal Transition in KRAS-Driven Cancer |
| Q34568607 | TP53: a key gene in human cancer. |
| Q37260683 | Targeting the p53 pathway |
| Q42008941 | The BCL-2 5′ Untranslated Region Contains an RNA G-Quadruplex-Forming Motif That Modulates Protein Expression |
| Q40216814 | The BCL2 major breakpoint region (mbr) regulates gene expression |
| Q37455886 | The i-motif in the bcl-2 P1 promoter forms an unexpectedly stable structure with a unique 8:5:7 loop folding pattern |
| Q35181974 | The immunoglobulin heavy chain gene 3' enhancers induce Bcl2 deregulation and lymphomagenesis in murine B cells |
| Q51583482 | The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells. |
| Q36542788 | The impact of post-transcriptional regulation in the p53 network |
| Q39488712 | The natural diterpene ent-16β-17α-dihydroxykaurane down-regulates Bcl-2 by disruption of the Ap-2α/Rb transcription activating complex and induces E2F1 up-regulation in MCF-7 cells |
| Q35878526 | The relative contribution of pro-apoptotic p53-target genes in the triggering of apoptosis following DNA damage in vitro and in vivo |
| Q39677796 | The retinoblastoma protein binds the promoter of the survival gene bcl-2 and regulates its transcription in epithelial cells through transcription factor AP-2. |
| Q91741764 | The role of microRNA in the resistance to treatment of hepatocellular carcinoma |
| Q38981518 | The role of the p53 protein in nitrosative stress-induced apoptosis of PC12 rat pheochromocytoma cells |
| Q36546440 | The tissue dependent interactions between p53 and Bcl-2 in vivo |
| Q24273295 | The transcription factor p53: not a repressor, solely an activator |
| Q37181734 | To kill a tumor cell: the potential of proapoptotic receptor agonists |
| Q34963231 | Toll-like receptor 3 (TLR3) induces apoptosis via death receptors and mitochondria by up-regulating the transactivating p63 isoform alpha (TAP63alpha). |
| Q64265490 | Transcriptional regulation of Bcl-2 gene by the PR/SET domain family member PRDM10 |
| Q44522476 | Transcriptional regulation of mitotic checkpoint gene MAD1 by p53. |
| Q35116644 | Transcriptional repression mediated by the p53 tumour suppressor |
| Q37068043 | Transduction of Recombinant M3-p53-R12 Protein Enhances Human Leukemia Cell Apoptosis |
| Q40408487 | TrkA induces apoptosis of neuroblastoma cells and does so via a p53-dependent mechanism |
| Q34058409 | Tumor suppressor protein p53 recruits human Sin3B/HDAC1 complex for down-regulation of its target promoters in response to genotoxic stress |
| Q34202703 | p53 Isoforms: An Intracellular Microprocessor? |
| Q34388165 | p53 acts as a co-repressor to regulate keratin 14 expression during epidermal cell differentiation |
| Q37602510 | p53 and E2f: partners in life and death |
| Q33376888 | p53 induces distinct epigenetic states at its direct target promoters |
| Q42457086 | p53 mediates density-dependent growth arrest. |
| Q38334966 | p53 suppresses c-Myb-induced trans-activation and transformation by recruiting the corepressor mSin3A. |
| Q38366523 | p53, a translational regulator: contribution to its tumour-suppressor activity. |
| Q40022446 | p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter |
Search more.